Pain Mechanisms of Knee Joint Osteoarthritis

膝关节骨关节炎的疼痛机制

基本信息

  • 批准号:
    8373029
  • 负责人:
  • 金额:
    $ 32.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Patients suffering from persistent knee joint pain typically have cartilage degeneration with structural and morphological changes in synovium, meniscus and subchondral bone at the damage knee joint region. Osteoarthritis is a leading cause of musculoskeletal-associated pain, psychological distress, impaired quality of life, and staggering socio-economic costs (estimated at $100 billion per year in the US alone). Currently, there is no effective treatment for this common affliction. Relief of knee joint pain is hampered because causative mechanisms (e.g., the pain source and affected cellular pathways) have not yet been established. To investigate the etiology of back pain and assess opportunities for possible clinical intervention, we will investigate specific signaling pathways leading to knee joit osteoarthritis and its symptom, knee pain by using representative tools: 1) established OA animal model model for facilitating behavioral pain assessments that allow us to investigate pain mechanisms, 2) genetically modified mice to understand pathophysiological nociceptive pathway evoked by knee osteoarthritis, and 3) investigation of peripheral (dorsal root ganglions) and central (spinal dorsal horn) responses by knee joint OA and roles of glial activation in chronic knee joint osteoarthritic pain. Our studies may uncover the nociceptive pathway that is impaired in OA condition, and may reveal that alleviation of OA pain at the spinal level is indeed beneficial to the joints by arresting progressive cartilage destruction through neurogenic attenuation. Successful completion of these studies will establish that effective controls of the PKC axis not only protects peripheral knee joint tissues from further degeneration, but also relieves its clinically debilitating symptom, pain, that profoundly impacts on the quality of life or a vast number of patients. PUBLIC HEALTH RELEVANCE: This application provides a unique opportunity to study nociceptive pathway initiated by osteoarthritis by combining genetically modified mice and established translational animal models that are amenable to behavioral pain tests that have set the stage for rapid advances in this highly under-studied area. Our results will discover a novel nociceptive pathway and molecular mechanisms that cannot be addressed by clinical protocols in humans, and will establish new experimental avenues and novel research directions for osteoarthritis-caused knee joint pain.
描述(由申请方提供):持续性膝关节疼痛患者通常在膝关节损伤区域发生软骨退化,滑膜、半月板和软骨下骨发生结构和形态学变化。骨关节炎是肌肉系统相关疼痛、心理困扰、生活质量受损和惊人的社会经济成本(仅在美国估计每年就有1000亿美元)的主要原因。目前,对这种常见的痛苦没有有效的治疗方法。膝关节疼痛的缓解受到阻碍,因为致病机制(例如,疼痛源和受影响的细胞通路)尚未建立。为了研究背痛的病因并评估可能的临床干预机会,我们将使用代表性工具研究导致膝关节骨性关节炎及其症状膝关节疼痛的特定信号通路:1)建立了用于促进行为疼痛评估的OA动物模型,使我们能够研究疼痛机制,2)遗传修饰小鼠以了解膝骨关节炎诱发的病理生理伤害感受通路,(3)周边调查(背根神经节)和中枢(脊髓背角)的反应以及胶质细胞活化在慢性膝关节骨关节炎疼痛中的作用。我们的研究可能揭示OA条件下受损的伤害性通路,并可能揭示在脊柱水平缓解OA疼痛确实有益于关节,通过神经源性衰减阻止进行性软骨破坏。这些研究的成功完成将确定PKC轴的有效控制不仅保护外周膝关节组织免于进一步退化,而且还减轻其临床上使人衰弱的症状,疼痛,这对生活质量或大量患者产生深刻影响。 公共卫生相关性:该申请提供了一个独特的机会,通过结合基因修饰小鼠和建立的翻译动物模型,研究骨关节炎引发的伤害性通路,这些动物模型适合于行为疼痛测试,为这一高度欠研究的领域的快速发展奠定了基础。我们的研究结果将发现一个新的伤害性通路和分子机制,不能在人类的临床协议解决,并将建立新的实验途径和新的研究方向骨关节炎引起的膝关节疼痛。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hee-Jeong Im Sampen其他文献

Hee-Jeong Im Sampen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hee-Jeong Im Sampen', 18)}}的其他基金

BLRD Research Career Scientist Award Application.
BLRD 研究职业科学家奖申请。
  • 批准号:
    10366566
  • 财政年份:
    2021
  • 资助金额:
    $ 32.76万
  • 项目类别:
BLRD Research Career Scientist Award Application.
BLRD 研究职业科学家奖申请。
  • 批准号:
    10513327
  • 财政年份:
    2021
  • 资助金额:
    $ 32.76万
  • 项目类别:
ShEEP Request for IVIS SPECTRUMCT, 2D and 3D Optical In Vivo Tomography System.
ShEEP 请求 IVIS SPECTRUMCT、2D 和 3D 光学体内断层扫描系统。
  • 批准号:
    9907225
  • 财政年份:
    2019
  • 资助金额:
    $ 32.76万
  • 项目类别:
Osteoarthritis and Knee Joint Pain
骨关节炎和膝关节疼痛
  • 批准号:
    10427174
  • 财政年份:
    2014
  • 资助金额:
    $ 32.76万
  • 项目类别:
OSTEOARTHRITIS AND KNEE JOINT PAIN
骨关节炎和膝关节疼痛
  • 批准号:
    8737435
  • 财政年份:
    2014
  • 资助金额:
    $ 32.76万
  • 项目类别:
Osteoarthritis and Knee Joint Pain
骨关节炎和膝关节疼痛
  • 批准号:
    10549317
  • 财政年份:
    2014
  • 资助金额:
    $ 32.76万
  • 项目类别:
OSTEOARTHRITIS AND KNEE JOINT PAIN
骨关节炎和膝关节疼痛
  • 批准号:
    8967105
  • 财政年份:
    2014
  • 资助金额:
    $ 32.76万
  • 项目类别:
Osteoarthritis and Knee Joint Pain
骨关节炎和膝关节疼痛
  • 批准号:
    10155426
  • 财政年份:
    2014
  • 资助金额:
    $ 32.76万
  • 项目类别:
Pain Mechanisms of Knee Joint Osteoarthritis
膝关节骨关节炎的疼痛机制
  • 批准号:
    8502248
  • 财政年份:
    2012
  • 资助金额:
    $ 32.76万
  • 项目类别:
Pathological Role of bFGF in Human Adult Articular Cartilage
bFGF 在人类成人关节软骨中的病理作用
  • 批准号:
    7847270
  • 财政年份:
    2009
  • 资助金额:
    $ 32.76万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.76万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了